Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Circulatory System Drugs (Find 10 items)

Circulatory System Drugs

Rosuvastatin

(287714-41-4)
Rosuvastatin Calcium is a competitive inhibitor of HMG-CoA reductase with IC50 of 11 nM.

Product List

Request for quotation , get quotes from more suppliers.

Rosuvastatin calcium

(147098-20-2)
Rosuvastatin calcium is an anti-hyperlipidemia drug. It is an HMG-CoA reductase inhibitor. It was successfully developed by AstraZeneca in the United Kingdom. It is suitable for the treatment of various lipid abnormalities, including hypercholesterolemia and mixed lipids. Qualitative disorders and simple hypertriglyceridemia. Rosuvastatin calcium is a statin with the strongest lipid-lowering effect and the most comprehensive lipid-lowering effect among the currently marketed lipid-lowering drugs

Product List

Request for quotation , get quotes from more suppliers.

Ramipril

(87333-19-5)
Angiotensin-converting enzyme (ACE) removes the C-terminal dipeptide from angiotensin I to form angiotensin II, a powerful vasoconstrictor. ACE is a key regulator of the renin-angiotensin system and an important drug target for the treatment of hypertension, congestive heart failure, and heart attacks, and also in preventing renal and retinal complications in diabetes. Ramipril is a second generation ACE inhibitor (IC50 = 4 nM) that acts as a prodrug, which is hydrolyzed in vivo to the active me

Product List

Request for quotation , get quotes from more suppliers.

Riociguat

(625115-55-1)
Riocguat is used in the treatment for pulmonary hypertension.

Product List

Request for quotation , get quotes from more suppliers.

Rilmenidine

(54187-04-1)
I1-imidazoline binding site ligand and a2-adrenoceptor agonist, exhibits higher I1 vs. a2 selectivity than clonidine

Product List

Request for quotation , get quotes from more suppliers.

Resibufogenin

(465-39-4)
Resibufogenin, a component of huachansu, has been shown to exhibit the anti-proliferative effect against cancer cells, and this may be attributed to the degradation of cyclin D1 caused by the activation of GSK-3β.IC50 Value:Target:In vitro: The effects of Resibufogenin on the outward delayed rectifier potassium current (IK) and outward transient potassium current (IA) in rat hippocampal neurons was investigated, and it inhibited both IK and IA, at 1 μM concentration RBG could alter some

Product List

Request for quotation , get quotes from more suppliers.

Ramiprilat

(87269-97-4)
A metabolite of Ramipril (R111000).

Product List

Request for quotation , get quotes from more suppliers.

Circulatory system drugs are about drugs that have the function of regulating the human circulatory system. The circulatory system is a system of body fluids (including blood, lymph and tissue fluids) and pipes through which circulation flows. Circulatory system drugs mainly include cardiovascular system drugs and diuretics. "Circulatory System Drugs" on ECHEMI covers lipid regulating drugs, angina pectoris drugs, calcium channel blockers, anti-congestive heart failure drugs, antihypertensive drugs, antiarrhythmics drugs, anti shock vasoactive drugs, ace inhibitor, peripheral vasodilators, heart failure treatments and drugs, Anti-atherosclerotic drugs, β-adrenergic receptor blockers and other circulatory system drugs, mainly supply raw materials for such drugs.

Frequently Asked Questions

What are circulatory system drugs used for?

Circulatory system drugs are medications designed to treat conditions affecting the heart and blood vessels. They are commonly used to manage hypertension (high blood pressure), heart failure, arrhythmias, angina, and to prevent blood clots. These drugs help regulate blood flow, reduce cardiac workload, and improve overall cardiovascular function, playing a critical role in both acute and chronic cardiovascular care.

What are the main types of circulatory system medications?

The main types of circulatory system drugs include:1. Antihypertensives (e.g., ACE inhibitors, beta-blockers, calcium channel blockers) for lowering blood pressure.2. Antiarrhythmics to stabilize irregular heart rhythms.3. Vasodilators that widen blood vessels to improve blood flow.4. Anticoagulants and antiplatelets (e.g., warfarin, aspirin) to prevent clot formation.5. Diuretics to reduce fluid buildup and lower blood pressure.Each class targets specific mechanisms within the cardiovascular system to achieve therapeutic effects.

How do I choose a reliable supplier for circulatory system APIs?

To choose a reliable supplier for circulatory system active pharmaceutical ingredients (APIs), consider the following criteria:1. Regulatory compliance—ensure the supplier holds certifications such as GMP, FDA approval, or EMA authorization.2. Quality assurance—verify robust testing protocols, documentation (e.g., COA, DMF), and traceability of raw materials.3. Manufacturing consistency—assess batch-to-batch reproducibility and scalability.4. Technical support and regulatory expertise to assist with global market requirements.Selecting a vetted, experienced API manufacturer minimizes risk and ensures drug safety and efficacy.

What quality standards apply to circulatory system drug intermediates?

Circulatory system drug intermediates must adhere to stringent quality standards to ensure final drug safety and performance. Key standards include compliance with ICH guidelines, GMP (Good Manufacturing Practice), and pharmacopeial specifications (e.g., USP, EP). Impurity profiles, residual solvents, and structural identity must be rigorously controlled. Reputable manufacturers conduct comprehensive analytical testing (HPLC, GC, NMR) and maintain full documentation for regulatory submissions.

Are there common side effects associated with circulatory system medications?

Yes, circulatory system drugs may cause side effects depending on the drug class. For example:- Beta-blockers can lead to fatigue, cold extremities, or bradycardia.- ACE inhibitors may cause a persistent dry cough or hyperkalemia.- Diuretics might result in electrolyte imbalances or dehydration.- Anticoagulants increase bleeding risk.Patients should always use these medications under medical supervision, and healthcare providers monitor for adverse reactions to optimize therapy safety and effectiveness.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.